Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 806 results for "novartis ag"

Cape Cod Five Cents Savings Bank Acquires 3,553 Shares of Nova...

Cape Cod Five Cents Savings Bank raised its stake in shares of Novartis AG (NYSE:NVS) by 5.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 69,157 shares of the company's stock after buying an ... Ticker Report, 4 hours ago
Novartis AG (NVS) Position Lowered by Cardinal Capital Management American Banking News - Forex, 11 hours ago

13 images for novartis ag

Channel NewsAsia, 1 week ago
Nasdaq, 1 week ago
Nasdaq, 1 week ago
Business Times Singapore, 1 week ago
Nasdaq, 1 week ago
BioSpace, 1 week ago
Nasdaq, 1 week ago
BioSpace, 1 week ago
BioSpace, 1 week ago
BioSpace, 1 week ago

Novartis Q4 Profit Declines

Swiss drug maker Novartis AG (NVS) Wednesday reported a 29 percent decline in profit for the fourth quarter from last year, reflecting lower sales. Looking ahead, Novartis expects 2016 group net sales and core operating income to be broadly in ...
 RTTNews.com1 week ago Novartis Q4 Profit Down; Sees 2016 Core Operating Broadly In Line With Last Year  RTTNews.com1 week ago

Pandemic Influenza Global Clinical Trials Review, H2, 2015 - Analysis, Technologies & Forecast Report - Key Vendors: Novartis AG, Sanofi & GlaxoSmithKline - Research and Markets

DUBLIN--(BUSINESS WIRE)-- Research and Markets ( ) has announced the addition of the "Pandemic Influenza Global Clinical Trials Review, H2, 2015" report to their offering. The clinical ...
 Yahoo! Finance UK and Ireland2 days ago BRIEF-Novartis CEO says emerging markets will slow thru 2016 driven by China, Russia  Reuters1 week ago Poisoning Global Clinical Trials Review, H2, 2015 - Key Vendors: Novartis AG, Altasciences Company Inc & Baxalta Incorporated - Research and Markets  Minyanville2 weeks ago Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2015 - Research and Markets  4 Traders8 hours ago

Radius (RDUS) Collaborates With Novartis Targeting Cancer

Radius Health, Inc. RDUS announced a worldwide collaboration with Novartis AG NVS for the evaluation of the efficacy and safety of combining its RAD1901 with Novartis LEE011 (ribociclib). Under the collaboration agreement, Radius and Novartis will ...
 Yahoo! Finance1 week ago
MSN Philippines

Novartis profits jump 73% on asset sales

Provided by AFP Net profit jumps 73% at Novartis to $17.7 bn thanks to asset sales, the Swiss pharmaceutical giant says Net profits jumped 73 percent at Novartis last year to $17.7 billion (16.1 billion euros) thanks to asset sales, the Swiss ...
 MSN Philippines1 week ago
Gulf News

Novartis Fourth-Quarter Profit Misses Estimates Amid Alcon Woes

(Bloomberg) -- Novartis AG, Europe's second-largest drugmaker, posted fourth-quarter earnings that missed analysts estimates as sales at its Alcon eye-care unit continued to plummet and the strength of the U.S. dollar eroded the value of global ...
 La Repubblica1 week ago Novartis Quarterly Profit Misses Estimates Amid Alcon Woes  Bloomberg1 week ago

Novartis (NVS) Is Weak On High Volume Today

Trade-Ideas LLC identified Novartis ( NVS) as a weak on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified Novartis as such a stock due to the following factors: NVS has an average dollar-volume (as ...
 TheStreet.com1 week ago

BRIEF-Novartis ag says deals to augment Alcon below $1 bln level

Jan 27 Novartis Ag * Says deals to add new products to Alcon below $1 billion level * Swiss drugmaker says transactions including potential licensing agreements would involve small companies Source text for Eikon: Further company coverage: ...
 Reuters1 week ago

Novartis Says Deals May Be One Way to Heal Troubled Alcon Unit

(Bloomberg) -- Novartis AG is scanning the market for acquisitions and licensing opportunities as low valuations create opportunities, especially deals to bolster its ailing eye-care unit Alcon, Chief Executive Officer Joe Jimenez said. Alcon, ...
 La Repubblica1 week ago

20-F - NOVARTIS AG (0001114448) (Filer)

Filed: 2016-01-27 AccNo: 0001047469-16-009872 Size:
 SEC1 week ago IRANNOTICE - NOVARTIS AG (0001114448) (Filer)  SEC1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - novartis ag
Get updated on latest news & your favorite topics right in your inbox!
More     Less